Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study

Recent studies showed that a low 25-hydroxyvitamin D (25(OH)D) level was associated with a higher risk of morbidity and severe course of COVID-19. Our study aimed to evaluate the effects of cholecalciferol supplementation on the clinical features and inflammatory markers in patients with COVID-19. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Karonova, Tatiana L., Golovatyuk, Ksenia A., Kudryavtsev, Igor V., Chernikova, Alena T., Mikhaylova, Arina A., Aquino, Arthur D., Lagutina, Daria I., Zaikova, Ekaterina K., Kalinina, Olga V., Golovkin, Alexey S., Grant, William B., Shlyakhto, Evgeny V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268385/
https://www.ncbi.nlm.nih.gov/pubmed/35807783
http://dx.doi.org/10.3390/nu14132602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268385/
https://www.ncbi.nlm.nih.gov/pubmed/35807783
http://dx.doi.org/10.3390/nu14132602

Ejemplares similares